What are the triggers and phenotypes in the pediatric age group that consensus, guidelines, and evidence suggest should be treated with topical therapies, and what symptomatic, historical, or skin-based findings suggest a need to intensify therapy?

What are the triggers and phenotypes in the pediatric age group that consensus, guidelines, and evidence suggest should be treated with topical therapies, and what symptomatic, historical, or skin-based findings suggest a need to intensify therapy?

CLICK HERE FOR CME CREDIT Back to Symposium

What are the triggers and phenotypes in the pediatric age group that consensus, guidelines, and evidence suggest should be treated with topical therapies, and what symptomatic, historical, or skin-based findings suggest a need to intensify therapy? 

Created by

CMEducation Resources iQ&A Case-By-Case Atopic Dermatitis Medical Intelligence Zone

Presenter

Lawrence Eichenfield, MD

Lawrence Eichenfield, MD

Chief of Pediatric and Adolescent Dermatology
Rady Children's Hospital-San Diego
Vice Chair, Department of Dermatology
Professor of Dermatology and Pediatrics
UC San Diego School of Medicine